Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice
Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice
复制标题
人参皂苷Rg1对脂多糖诱导的小鼠小胶质细胞活化的抑制作用
DOI:
10.1016/j.brainres.2010.11.069
复制
发表时间:
2011-02-16
期刊:
影响因子:
2.9
通讯作者:
Chen, Nai-Hong
中科院分区:
文献类型:
--
作者:
Hu, Jin-Feng;Song, Xiu-Yun;Chen, Nai-Hong
Microglial activation plays a pivotal role in the pathogenesis of neurodegenerative diseases by producing various pro-inflammatory cytokines and nitric oxide (NO). In the paper, the anti-inflammatory effect of ginsenoside Rg1 was investigated in mice intracerebroventricular injected of lipopolysaccharide (LPS). NO and tumor necrosis factor (TNF)-alpha production in both cerebral cortex and hippocampus decreased at dose-dependent manner by oral administration with Rg1. And the expression of ionized calcium binding adaptor molecule 1 (Iba-1) increased in both cerebral cortex and hippocampus in LPS-injected group compared to that in control group. However, Rg1 inhibited microglial activation by suppressing Iba-1 expression. In addition, the expression of inducible nitric oxide synthase (iNOS) was inhibited by Rg1. Moreover, Rg1 suppressed the phosphorylation level of I kappa B, nuclear translocation of p65 subunit of NF kappa B, and phosphorylation level of p38, ERK1/2, JNK mitogen-activated protein kinase (MAPK) induced by LPS. Concluding, Rg1 inhibited the inflammation mediated by LPS by suppressing NF kappa B and MAPK pathway, which provided the explanation for its therapeutic effect on neurodegenerative diseases. (C) 2010 Elsevier B.V. All rights reserved.